About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Understanding Primary CNS Lymphoma
Compassionate Use Policy
Pipeline
Pipeline Overview
CA-4948
Fimepinostat
CA-170
CA-327
Scientific Resources
Investors
Overview
Press Releases
Events & Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Studies Now Enrolling
Pipeline
Pipeline Overview
CA-4948
Fimepinostat
CA-170
CA-327
Scientific Resources
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Performance
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
Investor Alerts
Enter the email address that you used to subscribe to this list.
Email
About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Understanding Primary CNS Lymphoma
Compassionate Use Policy
Pipeline
Pipeline Overview
CA-4948
Fimepinostat
CA-170
CA-327
Scientific Resources
Investors
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Performance
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact